We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

New findings show that daily biomarker-guided testing can prompt antibiotic stop recommendations nearly two days earlier in ICU sepsis. More...
23 Oct 2026
Image: AI-Based Stepwise Prediction Framework for Immunotherapy Response: A Machine-Learning Approach for Predicting Responders and Non-Responders Based on Tumor Cell Senescence (Photo courtesy of POSTECH)

AI Tool Predicts Immunotherapy Response Using Tumor Senescence Signals

An AI approach predicts immunotherapy response by accounting for tumor senescence, outperforming biomarkers across cancers. More...
22 Oct 2026
Image: Clinical single-cell profiling at diagnosis may help guide more personalized treatment for difficult-to-treat cancers. (Image Credit: Adobe Stock)

Single-Cell Profiling Reveals Chemotherapy Resistance Signals in Ovarian Cancer

Clinical single-cell profiling at diagnosis could help guide more personalized treatment strategies for difficult-to-treat cancers. More...
22 Oct 2026
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Waters Corporation and Quest Diagnostics have formed a collaboration to broaden access to the FDA-cleared Onclarity Self-Collection Kit. More...
22 Oct 2026
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

A new blood test predicts Alzheimer’s progression up to six years before symptoms by measuring a disease-related protein marker. More...
22 Oct 2026
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

New findings show blood protein profiling years before diagnosis signals prostate cancer risk. More...
22 Oct 2026
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

An AI approach using vision transformers boosts detection of precancerous colon polyps to 70% sensitivity, 86% accuracy. More...
22 Oct 2026
Visit expo >
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240

In Other News

Copyright © 2000 - 2026 Globetech Media.
All rights reserved.